AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-04906-1-3
Submission Type
New dosing schedule
Decision
Approved